×ðÁú¿­Ê±

English
×ðÁú¿­Ê±¡¤(ÖйúÇø)ÈËÉú¾ÍÊDz«!

½²×ù±¨¸æ

×ðÁú¿­Ê±¡¤(ÖйúÇø)ÈËÉú¾ÍÊDz«!

¿ÂºâÃ÷£ºCyclic nucleotide phosphodiesterases and its application

½²×ù±àºÅ£ºjz-yjsb-2019-y077

½²×ùÎÊÌ⣺Cyclic nucleotide phosphodiesterases and its application

Ö÷ ½² ÈË£º¿ÂºâÃ÷   The University of North Carolina at Chapel Hill

½²×ùʱ¼ä£º2019Äê12ÔÂ06ÈÕ£¨ÐÇÆÚÎ壩ÏÂÖç16:10

½²×ùËùÔÚ£º¸·³É·Î÷УÇø½ÌÈýÂ¥348ÊÒ

¼ÓÈ빤¾ß£ºÇṤ¿ÆѧÊÖÒÕѧԺȫÌåʦÉú£¬È«Ð£¶Ô½²×ù¸ÐÐËȤµÄʦÉú

Ö÷Àíµ¥Î»£ºÑо¿ÉúÔº

³Ð°ìµ¥Î»£ºÇṤ¿ÆѧÊÖÒÕѧԺ

Ö÷½²È˼ò½é£º

¿ÂºâÃ÷½ÌÊÚ£¬¹þ·ð´óѧÉúÎïÎïÀíѧ²©Ê¿£¬ÃÀ¹ú±±¿¨ÂÞÀ´ÄÉ´óѧ½ÌÌÃɽ·ÖУҽѧԺµÄÖÕÉí½ÌÊÚ£¬ÃÀ¹úNIHÊ×ϯ¿Æѧ¼Ò£¬Ê¦´Óŵ±´¶û»¯Ñ§½±»ñµÃÕßWilliam N. Lipscomb½ÌÊÚ¡£¿Â½ÌÊÚÔڽṹÉúÎïѧÑо¿·½ÃæÈ¡µÃÁËÌìÏÂ×ÅÃûµÄЧ¹û£¬ÒѾ­½â³öÁËPDEµÈ10ÀàÂÑ°×Öʵľ§Ìå½á¹¹¡£ÔÚCell£¬Science£¬Nature Struct. Biol.£¬Proc Natl Acad Sci U S A£¬J Biol Chem£¬J Med Chem.£¬Development£¬Biochem. Pharmacol.£¬Biochem J., J. Mol. Biol.µÈ¹ú¼ÊÖøÃûѧÊõÆÚ¿¯ÉϽÒÏþÂÛÎÄ80Óàƪ¡£ÊÇAmerican Crystallographic Association£¬American Association for the Advancement of Science ίԱ£¬J. Biological Sciences, Current Bioactive Compounds ±àί£¬ÒÔ¼°Proc. Natl. Acad. Sci., J. Mol. Biol.,J. Biol. Chem.£¬EMBO J.£¬Biochemistry£¬Structure£¬Protein: structure, function and genetics£¬Nature Structural BiologyµÈ¶¥¼¶ÆÚ¿¯µÄÉó¸åÈË¡£

Ö÷½²ÄÚÈÝ£º

Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP  and cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides, their signalling pathways and, consequently, myriad biological responses in health and disease. PDE inhibitors are used clinically for treating the pathophysiological dysregulation of cyclic nucleotide signalling inerectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease.

 

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿